Detection of BRAF V600 mutations in melanoma: evaluation of concordance between the Cobas® 4800 BRAF V600 mutation test and the methods used in French National Cancer Institute (INCa) platforms in a real-life setting

PloS One
Samia MourahJean-Philippe Merlio

Abstract

Vemurafenib is approved for the treatment of metastatic melanoma in patients with BRAF V600 mutation. In pivotal clinical trials, BRAF testing has always been done with the approved cobas 4800 BRAF test. In routine practice, several methods are available and are used according to the laboratories usual procedures. A national, multicenter, non-interventional study was conducted with prospective and consecutive collection of tumor samples. A parallel evaluation was performed in routine practice between the cobas 4800 BRAF V600 mutation test and home brew methods (HBMs) of 12 national laboratories, labelled and funded by the French National Cancer Institute (INCa). For 420 melanoma samples tested, the cobas method versus HBM showed a high concordance (93.3%; kappa = 0.86) in BRAF V600 genotyping with similar mutation rates (34.0% versus 35.7%, respectively). Overall, 97.4% and 98.6% of samples gave valid results using the cobas and HBM, respectively. Of the 185 samples strictly fulfilling the cobas guidelines, the concordance rate was even higher (95.7%; kappa = 0.91; 95%CI [0.85; 0.97]). Out of the 420 samples tested, 28 (6.7%) showed discordance between HBM and cobas. This prospective study shows a high concordance rate between ...Continue Reading

References

Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Nov 26, 2002·Nature Genetics·Pamela M PollockPaul S Meltzer
Mar 17, 2004·Molecular and Cellular Biology·Jane GoodallColin R Goding
Nov 18, 2005·The New England Journal of Medicine·John A CurtinBoris C Bastian
Feb 23, 2007·Nature·Vanessa Gray-SchopferRichard Marais
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·James TsaiGideon Bollag
Feb 28, 2008·Current Opinion in Oncology·Leslie A FecherKeith T Flaherty
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Feb 24, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Georgina V LongRichard F Kefford
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Nov 19, 2011·Journal of Biomedical Informatics·S Rubrichi, S Quaglini
Feb 7, 2012·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Harkanwal HalaitH Jeffrey Lawrence
Feb 24, 2012·The New England Journal of Medicine·Jeffrey A SosmanAntoni Ribas
Mar 3, 2012·Drugs of Today·R N AmariaA Jimeno
Mar 7, 2012·New Biotechnology·Suzanne ChengLin Wu
Jun 6, 2012·The New England Journal of Medicine·Keith T FlahertyUNKNOWN METRIC Study Group
Jun 16, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelElizabeth Ward
Jul 5, 2012·The British Journal of Dermatology·A M ForseaA C Geller
Jul 11, 2012·Nature Reviews. Clinical Oncology·Frédérique NowakFabien Calvo
Aug 15, 2012·Journal of the American Academy of Dermatology·Alexander SkorokhodPeter Helmbold
Nov 20, 2012·The Journal of Molecular Diagnostics : JMD·Johanne Lade-KellerLasse S Kristensen
Nov 24, 2012·Seminars in Cutaneous Medicine and Surgery·Jonathan L CurryVictor G Prieto
May 30, 2013·American Society of Clinical Oncology Educational Book·Frédérique NowakJean-Charles Soria
Sep 3, 2013·The Journal of Molecular Diagnostics : JMD·Kevin QuFrederic Waldman
Sep 13, 2013·The Journal of Investigative Dermatology·Mélanie Saint-JeanBrigitte Dréno

❮ Previous
Next ❯

Citations

Sep 29, 2017·Journal of Clinical Microbiology·Lance R PetersonMichael A Lewinski
Oct 24, 2018·Biological Chemistry·Elena ObradorJosé M Estrela
Jan 25, 2019·Genetic Testing and Molecular Biomarkers·Tatiana BurjanivovaLukas Plank
Feb 26, 2016·Oncotarget·Julie DelyonCéleste Lebbé
Nov 6, 2015·Journal of Clinical Pathology·Richard CollingElizabeth Soilleux
Apr 10, 2016·Experimental Dermatology·Anne CaudronSamia Mourah
Aug 18, 2017·Academic Pathology·Karen L KaulRichard B Thomson
Sep 3, 2020·Journal of Clinical Pathology·Fanélie JouenneAbdellatif Tazi
May 20, 2020·Seminars in Cancer Biology·Elena ObradorJosé M Estrela
Feb 14, 2021·Annales de dermatologie et de vénéréologie·E Funck-BrentanoP Saiag
Apr 4, 2021·International Journal of Molecular Sciences·Margaret Ottaviano On Behalf Of Scito Youth
Oct 11, 2020·Critical Reviews in Oncology/hematology·Umberto MalapelleGiancarlo Troncone

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
biopsies
PCR

Software Mentioned

Pyrosequencing
Excell
INCa

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.